182 related articles for article (PubMed ID: 8824283)
1. Binding of human phospholipase A2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activity.
Sartipy P; Johansen B; Camejo G; Rosengren B; Bondjers G; Hurt-Camejo E
J Biol Chem; 1996 Oct; 271(42):26307-14. PubMed ID: 8824283
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase A2 type II binds to extracellular matrix biglycan: modulation of its activity on LDL by colocalization in glycosaminoglycan matrixes.
Sartipy P; Bondjers G; Hurt-Camejo E
Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1934-41. PubMed ID: 9848887
[TBL] [Abstract][Full Text] [Related]
3. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
[TBL] [Abstract][Full Text] [Related]
4. Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: assessment of selectivity, heterogeneity and the participation of core proteins in binding.
Herndon ME; Stipp CS; Lander AD
Glycobiology; 1999 Feb; 9(2):143-55. PubMed ID: 9949192
[TBL] [Abstract][Full Text] [Related]
5. Heparan sulfate proteoglycans from mouse mammary epithelial cells. Basal extracellular proteoglycan binds specifically to native type I collagen fibrils.
Koda JE; Bernfield M
J Biol Chem; 1984 Oct; 259(19):11763-70. PubMed ID: 6237102
[TBL] [Abstract][Full Text] [Related]
6. Phospholipase A(2) modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycans.
Sartipy P; Camejo G; Svensson L; Hurt-Camejo E
J Biol Chem; 1999 Sep; 274(36):25913-20. PubMed ID: 10464335
[TBL] [Abstract][Full Text] [Related]
7. Lipolysis of LDL by human secretory phospholipase A(2) induces particle fusion and enhances the retention of LDL to human aortic proteoglycans.
Hakala JK; Oörni K; Pentikäinen MO; Hurt-Camejo E; Kovanen PT
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1053-8. PubMed ID: 11397719
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein binding affinity of arterial wall proteoglycans: characteristics of a chondroitin sulfate proteoglycan subfraction.
Srinivasan SR; Vijayagopal P; Eberle K; Radhakrishnamurthy B; Berenson GS
Biochim Biophys Acta; 1989 Nov; 1006(2):159-66. PubMed ID: 2512982
[TBL] [Abstract][Full Text] [Related]
9. Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats.
Klein DJ; Oegema TR; Brown DM
Diabetes; 1989 Jan; 38(1):130-9. PubMed ID: 2521210
[TBL] [Abstract][Full Text] [Related]
10. Cooperation of binding sites at the hydrophilic domain of cell-surface sulfatase Sulf1 allows for dynamic interaction of the enzyme with its substrate heparan sulfate.
Milz F; Harder A; Neuhaus P; Breitkreuz-Korff O; Walhorn V; Lübke T; Anselmetti D; Dierks T
Biochim Biophys Acta; 2013 Nov; 1830(11):5287-98. PubMed ID: 23891937
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate proteoglycans in the substratum adhesion sites of human neuroblastoma cells: modulation of affinity binding to fibronectin.
Vallen EA; Eldridge KA; Culp LA
J Cell Physiol; 1988 May; 135(2):200-12. PubMed ID: 2967301
[TBL] [Abstract][Full Text] [Related]
12. Chondroitin sulfate and heparan sulfate-containing proteoglycans are both partners and targets of basic fibroblast growth factor-mediated proliferation in human metastatic melanoma cell lines.
Nikitovic D; Assouti M; Sifaki M; Katonis P; Krasagakis K; Karamanos NK; Tzanakakis GN
Int J Biochem Cell Biol; 2008; 40(1):72-83. PubMed ID: 17706452
[TBL] [Abstract][Full Text] [Related]
13. Heparan sulfate-chondroitin sulfate hybrid proteoglycan of the cell surface and basement membrane of mouse mammary epithelial cells.
David G; Van den Berghe H
J Biol Chem; 1985 Sep; 260(20):11067-74. PubMed ID: 3161890
[TBL] [Abstract][Full Text] [Related]
14. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44.
Kawashima H; Hirose M; Hirose J; Nagakubo D; Plaas AH; Miyasaka M
J Biol Chem; 2000 Nov; 275(45):35448-56. PubMed ID: 10950950
[TBL] [Abstract][Full Text] [Related]
15. Age-related changes in populations of aortic glycosaminoglycans: species with low affinity for plasma low-density lipoproteins, and not species with high affinity, are preferentially affected.
Tovar AM; Cesar DC; Leta GC; Mourão PA
Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):604-14. PubMed ID: 9580254
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta.
Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
Biochim Biophys Acta; 1983 Jul; 758(1):70-83. PubMed ID: 6222769
[TBL] [Abstract][Full Text] [Related]
17. Ovarian carcinoma cells synthesize both chondroitin sulfate and heparan sulfate cell surface proteoglycans that mediate cell adhesion to interstitial matrix.
Kokenyesi R
J Cell Biochem; 2001 Aug 1-9; 83(2):259-70. PubMed ID: 11573243
[TBL] [Abstract][Full Text] [Related]
18. Human venous and arterial glycosaminoglycans have similar affinity for plasma low-density lipoproteins.
Leta GC; Mourão PA; Tovar AM
Biochim Biophys Acta; 2002 Apr; 1586(3):243-53. PubMed ID: 11997076
[TBL] [Abstract][Full Text] [Related]
19. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
Yeaman C; Rapraeger AC
J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for the association of group IIA phospholipase A(2) and decorin in human atherosclerotic lesions.
Sartipy P; Johansen B; Gâsvik K; Hurt-Camejo E
Circ Res; 2000 Mar; 86(6):707-14. PubMed ID: 10747008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
